Insmed Balance Sheet Health

Financial Health criteria checks 2/6

Insmed has a total shareholder equity of $-331.9M and total debt of $1.3B, which brings its debt-to-equity ratio to -394.8%. Its total assets and total liabilities are $1.3B and $1.7B respectively.

Key information

-394.8%

Debt to equity ratio

US$1.31b

Debt

Interest coverage ration/a
CashUS$780.45m
Equity-US$331.92m
Total liabilitiesUS$1.66b
Total assetsUS$1.33b

Recent financial health updates

Recent updates

Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Feb 25
Insmed Incorporated (NASDAQ:INSM) Just Released Its Yearly Results And Analysts Are Updating Their Estimates

Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Dec 18
Insmed Incorporated (NASDAQ:INSM) Investors Are Less Pessimistic Than Expected

Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Jul 28
Getting In Cheap On Insmed Incorporated (NASDAQ:INSM) Is Unlikely

Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jul 01
Calculating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

Apr 18
Would Insmed (NASDAQ:INSM) Be Better Off With Less Debt?

A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Feb 23
A Look At The Fair Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed inks financing agreements to raise $500M

Oct 19

Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

Oct 17
Does Insmed (NASDAQ:INSM) Have A Healthy Balance Sheet?

An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Sep 20
An Intrinsic Calculation For Insmed Incorporated (NASDAQ:INSM) Suggests It's 46% Undervalued

Insmed rises 16% on better-than-expected Q2 result

Aug 04

Is Insmed (NASDAQ:INSM) A Risky Investment?

Jun 24
Is Insmed (NASDAQ:INSM) A Risky Investment?

Insmed: Temporarily Stuck

Feb 19

Is Insmed (NASDAQ:INSM) Using Debt Sensibly?

Dec 11
Is Insmed (NASDAQ:INSM) Using Debt Sensibly?

Is Insmed (NASDAQ:INSM) Using Too Much Debt?

Sep 10
Is Insmed (NASDAQ:INSM) Using Too Much Debt?

Estimating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Jun 10
Estimating The Intrinsic Value Of Insmed Incorporated (NASDAQ:INSM)

Insmed to raise $250M in stock offering, $500M in notes offering

May 10

We Think The Compensation For Insmed Incorporated's (NASDAQ:INSM) CEO Looks About Right

May 06
We Think The Compensation For Insmed Incorporated's (NASDAQ:INSM) CEO Looks About Right

Is Insmed (NASDAQ:INSM) Weighed On By Its Debt Load?

Apr 06
Is Insmed (NASDAQ:INSM) Weighed On By Its Debt Load?

Have Insiders Been Selling Insmed Incorporated (NASDAQ:INSM) Shares?

Mar 02
Have Insiders Been Selling Insmed Incorporated (NASDAQ:INSM) Shares?

Financial Position Analysis

Short Term Liabilities: INSM has negative shareholder equity, which is a more serious situation than short term assets not covering short term liabilities.

Long Term Liabilities: INSM has negative shareholder equity, which is a more serious situation than short term assets not covering long term liabilities.


Debt to Equity History and Analysis

Debt Level: INSM has negative shareholder equity, which is a more serious situation than a high debt level.

Reducing Debt: INSM's has negative shareholder equity, so we do not need to check if its debt has reduced over time.


Balance Sheet


Cash Runway Analysis

For companies that have on average been loss-making in the past, we assess whether they have at least 1 year of cash runway.

Stable Cash Runway: INSM has sufficient cash runway for more than a year based on its current free cash flow.

Forecast Cash Runway: INSM has sufficient cash runway for 1.2 years if free cash flow continues to reduce at historical rates of 15.1% each year.


Discover healthy companies

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Price

7D

1Y

Mkt cap

PS

E.Growth

Analysts Target

Simply Wall Street Pty Ltd (ACN 600 056 611), is a Corporate Authorised Representative (Authorised Representative Number: 467183) of Sanlam Private Wealth Pty Ltd (AFSL No. 337927). Any advice contained in this website is general advice only and has been prepared without considering your objectives, financial situation or needs. You should not rely on any advice and/or information contained in this website and before making any investment decision we recommend that you consider whether it is appropriate for your situation and seek appropriate financial, taxation and legal advice. Please read our Financial Services Guide before deciding whether to obtain financial services from us.